London, April 7 (IANS) A trial of the Oxford-AstraZeneca Covid-19 vaccine on children in the UK has been paused even as the country`s medicines regulator probes a possible link of the vaccine with rare blood clots in adults, the media reported.
The trial, which started in February, is evaluating whether the vaccine generates a strong immune response in those aged between 6 and 17.
While the trial has been paused, Professor Andrew Pollard from the University of Oxford ruled out safety concerns with the trial itself, the BBC reported on Wednesday.
What the scientists are waiting for is more information, said the report.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.